Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03760744 · ClinicalTrials.gov registry record · NA
Imaging Biomarkers of Lymphatic Dysfunction
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03760744 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 18 participants.
The verdict
NCT03760744, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Persons with secondary arm and/or upper quadrant lymphedema following cancer therapies commonly are prescribed complete decongestive therapy as a course of management of their lymphedema. The investigators will perform a repeated-measures cross-over trial to test the hypothesis that mobilization of protein enriched hardened tissue using graded negative pressure therapy in conjunction with complete decongestive therapy (CDT) is more effective to standard CDT alone for secondary lymphedema management.
Interventions
- PROCEDURE CDT with Negative Pressure
- PROCEDURE CDT alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2019-01-23 |
| Est. Completion | 2025-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03760744
The ClinicalTrials.gov registry entry for NCT03760744 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CDT with Negative Pressure is the first listed.
NCT03760744 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03760744 about?
NCT03760744 is a clinical study titled "Imaging Biomarkers of Lymphatic Dysfunction". Persons with secondary arm and/or upper quadrant lymphedema following cancer therapies commonly are prescribed complete decongestive therapy as a course of management of their lymphedema. The investigators will perform a repeated-measures cross-over trial to test the hypothesis that mobilization of ...
What is the current status of trial NCT03760744?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2019-01-23. Estimated completion is 2025-03-15.
What interventions are being tested in trial NCT03760744?
The interventions under investigation include: CDT with Negative Pressure (PROCEDURE), CDT alone (PROCEDURE).
Who is sponsoring clinical trial NCT03760744?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.